Daniel Calarese

Daniel Calarese

Company: Sutro Biopharma

Job title: Executive Director, Research Innovation

Seminars:

Development of Site-Specific, High-DAR Dual-Payload ADCs 3:30 pm

Addressing the clinical challenge of acquired resistance to single-payload ADCs by delivering two different payloads simultaneously to tumors Utilizing an innovative cell-free platform to create novel antibody-drug conjugates Showcasing dual-payload ADC approaches with superior preclinical in vitro and in vivo efficacyRead more

day: Scientific Program Day Two PM

12:00pm Panel Discussion: What is the Next Frontier Within ADC Payloads? 12:00 pm

What are the emerging trends in ADC payloads in APAC, the US and Europe? Exploring the most novel MOAs that are entering preclinical development and the value proposition of each compared to tubulin inhibitors and DNA damaging agents Considering the difference in physicochemical properties and PK profiles of next generation versus traditional ADC payloadsRead more

day: Day Two Discovery Track

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.